Metrics to compare | BVXP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBVXPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.5x | −4.5x | −0.2x | |
PEG Ratio | 58.69 | −0.01 | 0.00 | |
Price/Book | 9.0x | 1.9x | 2.6x | |
Price / LTM Sales | 7.9x | 4.1x | 2.8x | |
Upside (Analyst Target) | 98.0% | 107.8% | 65.0% | |
Fair Value Upside | Unlock | 1.7% | 9.6% | Unlock |
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene (HOP-G) ELISA kit, a sandwich enzyme-linked immunosorbent assay kit for the detection of 1-hydroxypyrene glucuronide in urine samples; and Pyrene (HOP-G) lateral kits, a positive read, semi-quantitative lateral flow testing system that allows for monitoring of at-risk individuals. It also provides an industrial and environmental biomonitoring platform, as well as contract SMAs services. The company was incorporated in 2003 and is based in Farnham, United Kingdom.